Freedman, M.H.

receptor g-csf mutation g-csf-r factor activation patient granulocyte colony-stimulating factor ligand p 206h mutation granulocyte domain binding p 206h wild-type colony-stimulating neutropenia analysis gcsfr extracellular domain clone concentration myeloid region response blood signal extracellular stat activation expression proliferation ligand binding sites growth differentiation g-csf treatment survival effect myeloid cells stat 5 ligand binding stat 3 www.jem.org december downloaded cytokine pe-conjugated streptavidin gcsfr mutations g-csfmediated proliferation receptor activation scn patient level g-csfmediated cytokine receptor treatment position pathway complex stat 3 activation novel g-csf-r mutation novel novel point mutation 100 ng /ml vector rpmi 1640 medium murine maturation g-csf concentrations gcsfr cdna protein scn patients bsihkai medium reduction figure myeloid 32 stats 1 1996. g-csf therapy wild-type receptor patient ar